Market Research Reports

  According to BIS Research, pharmaceutical aseptic transfer refers to the use of products that promote the aseptic transfer of both solid and liquid pharmaceutical products at every stage of the lifecycle, from manufacturing to packaging and distribution. According to this study, the global   pharmaceutical aseptic transfer market  was $855.2 million in 2021 and is projected to reach $2.55 billion by 2031. The following factors are responsible for the increase in demand for pharmaceutical aseptic transfer: Rapid expansion of the pharmaceutical industry Significant rise in investment in the pharmaceutical industry Implementation of stringent regulations for drug approval processes Growing demand for automated products for aseptic transfer processes The detailed study is a compilation of 27 market data tables and 226 figures spread through 270 pages.  Check out the detailed table of content here  →   https://bisresearch.com/requestsa...

  Plasma medicine has, in a remarkably short period of time, led to revelations across the entire clinical continuum from risk assessment in healthy individuals to the treatment of complex diseases. With the enormous treasure-trove of data about the human genome produced by the research, spawning a whole new era of digital technologies and systems, researchers and clinicians now have more robust tools to study the role that non-invasive factors have in complex diseases. Plasma medicine is a growing field combining plasma physics, biology, and clinical medicine and has an impact in several important areas in therapeutic patient care, combining plasma physics, biology, and clinical medicine. Earlier, plasmas in medicine were used in non-contact hemostasis and electrosurgery for cautery, while presently, non-thermal plasmas have attained widespread use in medicine due to their effectiveness and compatibility with biological systems. The most active areas of plasma technology applicati...

  The global radioligand therapy market comprises well-established and newly emerging companies. . Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the innovation in radioligand therapy from different sample types. The  global radioligand therapy market  was valued at $9.75 billion in 2020 and is projected to reach $16.65 billion by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 4.67% during the forecast period 2021-2031. In the comprehensive study of the global radioligand therapy market, BIS Research extensively covers the following: Market numbers on micro-segments influencing the market Market share analysis of key market players Growth share analysis of companies Impact of COVID-19 on the global radioligand therapy market Growth analysis by indication, product, biomarker, and r...

  Liquid biopsy is an essential part of medical decision-making and aids in obtaining information for a wide range of treatment dissemination. Liquid biopsy has a crucial role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics. The global   liquid biopsy market    was estimated to be at $2,508.2 million in 2021, which is expected to grow with a CAGR of 19.83% and reach $19,066.0 million by 2032. The growth in the global liquid biopsy market is expected to be driven by increasing adoption of NGS in various research fields, advancement in NGS, and increase in the adoption of personalized medicine.   Liquid biopsy can be used as a better alternative for treatment and recurrence monitoring as it overcomes invasive biopsy challenges of taking a tumor sample again and again during the course of the treatment. Next-generation sequencing (NGS) is a DNA sequencing technology that has transformed genomi...

  The cell and gene therapy market is the upcoming wave of therapeutic innovation in the healthcare and life sciences industry. However, the technology for manufacturing these therapies are still in t nascent stage. Furthermore, in 2020 significant number of financing was received by the company for cell and gene therapies in spite of economic challenges due to COVID-19 spread. The year was record breaking and the therapeutic developers of the cell and gene therapies raised more in the first half of the year than in the complete year 2019.  Cell and gene therapy are overlapping fields of biomedical research having similar therapeutic goals, which target DNA or RNA inside or outside the body. Both therapies aim at modifying genetic material for treatment of a disease. Gene therapy uses genetic material, or DNA, to manipulate a patient’s cells for the treatment of an inherited or acquired disease. Cell therapy is the introduction of new cells into a patient’s body to grow, repla...

  The global operating room (OR) management solutions market is a huge market comprised of various software solutions that are used in an operating room. These include solutions for data management, inventory management, scheduling and planning of surgeries, communication among surgical staff within and outside the OR, and improved visualization, reporting, and documentation, among others. The global  operating room management solutions market  report highlights that the market was valued at $2,023.5 million in 2021 and is expected to reach $3,699.1 million by the end of 2031. The market is expected to grow at a CAGR of 6.29% during the forecast period from 2022 to 2031.   Impact of COVID-19 on the Operating Room Management Solutions Market The COVID-19 pandemic led to a deferral of elective surgeries across various clinical areas, such as neurology and cardiology. The pandemic also placed heightened importance on the safety and sterilization protocols followed by th...

  The endoscopic imaging market has witnessed significant advancements over the past few years. It is anticipated to grow significantly during the forecast period owing to the growing adoption of minimally invasive procedures, the improving clinical quality of the endoscopic procedures, and the rising technology integration in endoscopic imaging systems. The  global endoscopic imaging systems market   is projected to reach  $6.94 billion  in terms of revenue by 2030, at a CAGR of 7.43%, suggests the premium market intelligence study by BIS Research. The comprehensive study of the global endoscopic imaging systems market by BIS Research extensively covers the market numbers based on the types of applications and region. It analyzes 15 companies offering endoscopic imaging systems along with a detailed global and regional market analysis, including the scrutiny of 10 key countries. Recent Developments in Global Endoscopic Imaging Systems Market •   ...